Thomas interviews people he finds interesting.
…
continue reading
Learn how to grow your business based and trust a relationship with your audience.
…
continue reading
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgica ...
…
continue reading
…
continue reading
1
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer
18:23
Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgc…
…
continue reading
1
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
25:05
Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversatio…
…
continue reading
1
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
23:16
Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas …
…
continue reading
1
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease
19:55
Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Foll…
…
continue reading
Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... http…
…
continue reading
1
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
16:39
Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this convers…
…
continue reading
Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on socia…
…
continue reading
1
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
14:40
Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_gen…
…
continue reading
1
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
14:45
Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=…
…
continue reading
Anna Emilie Kann (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue t…
…
continue reading
Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversati…
…
continue reading
Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases. Read the full article: https://www.thelancet.com/journals/langas/art…
…
continue reading
1
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
17:41
Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this c…
…
continue reading
1
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
12:48
Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis. Read the full article: https://www.…
…
continue reading
Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_…
…
continue reading
Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings. Read the Commission here: The cost of inflammatory bowel disease in high-income settings Continue this conversation on social! Fo…
…
continue reading
1
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
21:30
Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease. Read the full article: Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) Continue…
…
continue reading
1
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
20:20
Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma. Read the full article: Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINO…
…
continue reading
Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD. Read the full article: Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS) Continue this conversation on social! Follow us today at... https:…
…
continue reading
1
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
15:21
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection. Read the full article: Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT) Continue this conversa…
…
continue reading
James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease. Read the full article: COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory b…
…
continue reading
Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea. Read the full article: Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial Continue this convers…
…
continue reading
1
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
14:06
Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma. Read the full article: Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a singl…
…
continue reading
1
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
10:26
Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk. Read the full article: Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study Continue this conversation …
…
continue reading
Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease. Read the full article: Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistu…
…
continue reading
Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas. Read the full article: The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas Continue this conversation on social! Follow u…
…
continue reading
Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators. Read the full article: Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Continue this conversation on social! Follow us today…
…
continue reading
Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection. Read the full article: A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial Continue this conversation on social!…
…
continue reading
Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis. Read the full article: Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) Continue this conversation on social! Follow us today a…
…
continue reading
Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers. Read the full article: The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biolo…
…
continue reading
Emilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00368-X/fulltext Continue this conversation on social! Follow us today at... https://…
…
continue reading
Wendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00296-X/fulltext Continue this conversation on social! Follow us today at... https://twitter…
…
continue reading
Tim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup http…
…
continue reading
Raymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00147-3/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thel…
…
continue reading
Sigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00137-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thel…
…
continue reading
Caroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00074-1/fulltext Continue this conversation on social! Follow us today at... htt…
…
continue reading
Forrige uke sendte Thomas et brev til kundene våres for å dele noen tanker rundt hva som skjer med annonseringen fremover. Dette brevet deler han i dag med deg.EPISODE NOTESLast ned gratis bonus: https://link.moenco.no/bonusFå hjelp til annonsering: https://www.moenco.no/annonseringGratis intro kurs for Facebook: http://moenco.no/oppsett…
…
continue reading
Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30365-4/fulltext Continue this conversation on social! Follow us today at... https://tw…
…
continue reading
Facebook prøvde i 2018 å lansere CBO, campaign budget optimalisation - men endte opp med å trekke lanseringen på grunn av dårlig mottakelse. Hva er status i 2021?Last ned gratis bonus: https://link.moenco.no/bonusFå hjelp til annonsering: https://www.moenco.no/annonseringGratis intro kurs for Facebook: http://moenco.no/oppsett…
…
continue reading
Hvor stort budsjett bør du ha som en liten bedrift? I dagens episode forteller Thomas deg hva du må tenkte på, og hvilke vurderinger som må tas når du beregner annonseringsbudsjettet ditt.Di Thomas Moen
…
continue reading
Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00055-8/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://ins…
…
continue reading
I dagens episode forteller Thomas om hvilke 7 grep du kan ta om annonsene dine blir for dyre, og resultatene går nedover.Di Thomas Moen
…
continue reading
Hva skal til for å få en annonse til å bli suksessfull? I dagens episode deler Thomas de 3 viktigste elementene som må være på plass.Di Thomas Moen
…
continue reading
I denne episoden snakker Marte Klouman og jeg om hvordan du med små, smarte grep kan få flere til å handle i nettbutikken din.Di Thomas Moen
…
continue reading
Varme publikum er de mest lønnsomme publikummene du kan annonsere mot. I denne episoden gir Thomas sine beste tips til hvordan du kan annonsere best mulig til det varme publikummet ditt.Di Thomas Moen
…
continue reading
I denne episoden snakker Thomas om hvordan du kan bruke kald trafikk best mulig i din annonsering på Facebook.Di Thomas Moen
…
continue reading
Det er mange måter å annonsere og markedsføre seg på, og vi ser alt for ofte at bedrifter begrenser seg til kun én plattform. I denne episoden snakker Thomas om hvordan fokus på én plattform gjør deg sårbar for endringer i markedet.Di Thomas Moen
…
continue reading
Apple´s kommende Ios oppdatering sies å skulle begrense muligheten for sporing av eventer på IPhone. Hvordan vil dette påvirke annonseringen din? I dagens episode snakker Thomas om hvilke endringer som kommer, og hva du bør gjøre for å forberede deg.Di Thomas Moen
…
continue reading
Annonsering og e-post kan, brukt riktig, utgjøre en fantastisk symbiose. I dagens episode snakker jeg om hvordan du strategisk kan kombinere annonsering og e-post for best mulig effekt.Di Thomas Moen
…
continue reading
I dagens episoden deler jeg sjekklisten min for hva du MÅ gjennom hver eneste uke i Google Analytics.Di Thomas Moen
…
continue reading